Faculty of Medicine, Department of Medical Biology, Van Yuzuncu Yil University, Van, Turkey.
Faculty of Medicine, Department of Biochemistry, Harran University, Şanlıurfa, Turkey.
J Bioenerg Biomembr. 2018 Apr;50(2):107-116. doi: 10.1007/s10863-018-9749-9. Epub 2018 Mar 9.
Colorectal cancer (CRC) is the third most common tumor, malignant and has developed one of the main reasons of cancer mortality. According to studies conducted recently; carbonic anhydrase 9 (CAIX) is an especially attractive target for cancer therapy, in part since it is limited way expressed in normal tissues on the other hand in a wide variety of solid neoplasia are overexpressed. The aim of this study was to appreciate the effects of CAIX inhibitor, namely novel synthesized sulfonamide derivative (H-4i) with high affinity for CAIX, in CAIX-positive human colorectal cancer cell (HT-29) and CAIX-negative human normal embryonic kidney cell line (HEK-293). For this reason, we planned to investigate apoptotic, cytotoxic and oxidative stress activity of H-4i on HT-29 and HEK-293 cell lines. Cell viability determined by WST-1 assay afterwards IC values, apoptosis and cell cycle induction measured by flow cytometric analysis, intracellular free radical induction performed by reactive oxygen species (ROS) analyses. The IC value of the sulfonamide derivative compound was found to be very low, especially in HT-29 cells, when compared to human normal cells. This research found that H-4i significantly increased cytotoxicity and ROS production, caused significant signs of apoptosis level. High level of ROS and apoptosis lead to arrest the cell cycle and reduce cell survival. The most obvious finding to emerge from the analysis that novel synthesized sulfonamide derivative H-4i is effective on HT-29 more than HEK-293. Therefore, novel derivative H-4i might be used as an anti-cancer potential compound on CRC.
结直肠癌(CRC)是第三大常见肿瘤,恶性程度高,是癌症死亡的主要原因之一。根据最近的研究;碳酸酐酶 9(CAIX)是癌症治疗的一个特别有吸引力的靶点,部分原因是它在正常组织中的表达有限,另一方面在广泛的实体肿瘤中过度表达。本研究旨在评估 CAIX 抑制剂,即新型合成磺酰胺衍生物(H-4i)对 CAIX 阳性人结直肠癌细胞(HT-29)和 CAIX 阴性人正常胚胎肾细胞系(HEK-293)的影响。为此,我们计划研究 H-4i 对 HT-29 和 HEK-293 细胞系的凋亡、细胞毒性和氧化应激活性。通过 WST-1 测定法测定细胞活力,随后通过流式细胞术分析测定 IC 值、细胞凋亡和细胞周期诱导,通过活性氧(ROS)分析测定细胞内自由基诱导。磺酰胺衍生物化合物的 IC 值发现非常低,尤其是在 HT-29 细胞中,与正常人类细胞相比。这项研究发现,H-4i 显著增加了细胞毒性和 ROS 产生,导致凋亡水平显著升高。高水平的 ROS 和凋亡导致细胞周期停滞并降低细胞存活率。从分析中得出的最明显的发现是,新型合成磺酰胺衍生物 H-4i 对 HT-29 的效果比 HEK-293 更明显。因此,新型衍生物 H-4i 可能被用作 CRC 的潜在抗癌化合物。